Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Option Award |
2025-02-26 5:33 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
149,180 | $0 | 315,538 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:33 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
705 | $1 | 315,538 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:33 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
507 | $0.9561 | 315,538 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:32 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
680,000 | $0 | 1,393,405 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,792 | $1 | 1,393,405 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,513 | $0.9561 | 1,393,405 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:32 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
680,000 | $0 | 1,374,842 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,434 | $1 | 1,374,842 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,375 | $0.9561 | 1,374,842 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:31 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
680,000 | $0 | 1,371,803 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:31 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,792 | $1 | 1,371,803 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:31 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,375 | $0.9561 | 1,371,803 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:30 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
2,125,000 | $0 | 4,202,848 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:30 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
7,488 | $1 | 4,202,848 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:30 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
10,663 | $0.9561 | 4,202,848 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
30,456 | $1.15 | 167,570 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
129,593 | $1.15 | 716,710 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
129,549 | $1.15 | 697,651 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
129,242 | $1.15 | 694,970 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
412,584 | $1.15 | 2,095,999 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
505 | $1.94 | 201,863 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
721 | $1.88 | 201,863 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,371 | $1.94 | 827,200 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
1,430 | $1.88 | 827,200 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,508 | $1.94 | 841,303 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,787 | $1.88 | 841,303 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,371 | $1.94 | 824,212 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
1,787 | $1.88 | 824,212 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
10,642 | $1.94 | 2,508,583 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:07 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
7,473 | $1.88 | 2,508,583 (Direct) |
View |
Ownership |
2024-10-28 4:11 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
0 | $0 | 380,002 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:38 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
2,801 | $0.86 | 830,001 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:38 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH |
1,196 | $0.86 | 193,923 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:37 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
3,158 | $0.86 | 827,370 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:37 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
3,295 | $0.86 | 844,598 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:36 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
12,753 | $0.86 | 2,526,698 (Direct) |
View |
| 2024-08-13 Tax Withholding |
2024-08-15 4:34 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
892 | $0.9751 | 832,802 (Direct) |
View |
| 2024-06-11 Tax Withholding |
2024-06-13 4:42 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
892 | $0.6077 | 830,528 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:26 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director |
75,000 | $0 | 127,100 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:25 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director |
75,000 | $0 | 137,600 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:25 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director |
75,000 | $0 | 124,600 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:24 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Markels John Director |
75,000 | $0 | 121,384 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:24 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director |
75,000 | $0 | 107,650 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:23 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director |
75,000 | $0 | 124,600 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:23 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director |
75,000 | $0 | 124,600 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:23 pm |
N/A 2034-06-03 |
SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director |
75,000 | $0 | 107,650 (Direct) |
View |
| 2024-05-24 Tax Withholding |
2024-05-29 5:18 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
3,295 | $0.6 | 842,893 (Direct) |
View |
| 2024-05-24 Tax Withholding |
2024-05-29 5:15 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
2,736 | $0.6 | 833,694 (Direct) |
View |
| 2024-05-24 Tax Withholding |
2024-05-29 5:00 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH |
1,195 | $0.6 | 195,119 (Direct) |
View |
| 2024-05-24 Tax Withholding |
2024-05-29 4:57 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
3,158 | $0.6 | 831,420 (Direct) |
View |
| 2024-05-24 Tax Withholding |
2024-05-29 4:54 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
12,753 | $0.6 | 2,539,451 (Direct) |
View |
| 2024-02-24 Tax Withholding |
2024-02-27 5:14 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH |
4,668 | $1.13 | 196,314 (Direct) |
View |
| 2024-02-24 Tax Withholding |
2024-02-27 5:13 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
7,832 | $1.13 | 836,430 (Direct) |
View |
| 2024-02-24 Tax Withholding |
2024-02-27 5:13 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
10,484 | $1.13 | 846,188 (Direct) |
View |
| 2024-02-24 Tax Withholding |
2024-02-27 5:12 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
8,927 | $1.13 | 834,578 (Direct) |
View |